Physician profile
Dillon C Oneill
NPI 1902302607
$7,112.59
in general payments reported to CMS, 2019-2025
8 companies · $4,492 in 2025
The $4,492 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.52 · 2021: $173 · 2022: $563 · 2023: $894 · 2024: $938 · 2025: $4,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,094 · Food and Beverage: $1,718 · Consulting Fee: $1,500 · Education: $12.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,093.71 |
| Food and Beverage | $1,718.07 |
| Consulting Fee | $1,500.00 |
| Education | $12.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,399.48 | 2021-2025 | Pro, Variax, Bio4 |
| Synthes Gmbh | $2,701.55 | 2025 | |
| Globus Medical, INC. | $675.51 | 2023 | Caliber, Distal Femur Plate System, Evo Antegrade |
| My01 INC. | $144.48 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Depuy Synthes Sales INC. | $91.99 | 2025 | Lcp, Tfn-Advance, Na |
| Smith+Nephew, INC. | $46.06 | 2024 | Polarstem, R3 Acetabular, Or3o Dual Mobility |
| Active Medical, LLC | $35.71 | 2019 | |
| Acumed LLC | $17.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dillon Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.